NCT05538091
- Conditions
- Hedgehog Inhibitor, PARP Inhibitor, Platinum-Resistant Fallopian Tube Carcinoma, +1 more
- Locations
-
- UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
Clinical trial condition
Explore clinical trials studying PARP Inhibitor. Study availability and eligibility vary by location and protocol.
NCT05538091
NCT06710548
NCT06197581
NCT06838429
Not specified
NCT07303218
NCT03212742